EU approves first long-acting HIV treatment for teens

EU approves first long-acting HIV treatment for teens#approves #longacting #HIV #treatment #teens

Morgan Stanley upgrades Gilead on HIV treatment growth By Investing.com

Investing.com — Morgan Stanley upgraded Gilead Sciences Inc (NASDAQ:) to “overweight” from “equal weight,” raising its price…

Gilead Sciences: 2025 Preview, A Buy Thanks To Thriving HIV Franchise

Gilead Sciences: 2025 Preview, A Buy Thanks To Thriving HIV Franchise #Gilead #Sciences #Preview #Buy #Thriving…

New HIV prevention drug could reach poorest countries by 2025, says health official By Reuters

By Jennifer Rigby LONDON (Reuters) – A new long-acting preventive HIV drug could reach the world’s…